Market Overview - A-shares have shown a continuous fluctuation since the fourth quarter, with the Shanghai Composite Index returning to 3900 points on October 21, 2023, and all three major A-share indices closing higher [1][2] - As of October 21, the Shanghai Composite Index, Shenzhen Component Index, and ChiNext Index reported increases of 1.36%, 2.06%, and 3.02% respectively, with year-to-date increases of 16.84%, 25.57%, and 43.99% [2] New Investor Activity - In September 2023, A-share new account openings reached 2.9372 million, a year-on-year increase of 60.73% and a month-on-month increase of 10.83%, marking the second-highest monthly figure of the year [2][3] - Institutional new account openings also reached 10,914, the second-highest monthly record in nearly four years [2] Investment Strategies - Multiple public funds have released their fourth-quarter strategies, with a general optimism towards the long-term performance of the Chinese stock market, particularly in sectors like technology, robotics, and innovative pharmaceuticals [3][5] - Some institutions, such as招商基金, express caution regarding short-term performance, indicating that further market increases may require additional policy or economic support [3] Sector Performance - The AI, innovative pharmaceuticals, and technology sectors have shown significant performance this year, with the STAR Market Composite Index, STAR 50, and Shanghai Pharmaceutical Index increasing by 44.65%, 42.21%, and 13.14% respectively [4] - Funds focusing on these sectors have also reported impressive returns, with some achieving over 175% year-to-date returns [4] Debt Market Outlook - The bond market is currently experiencing a "stock-bond seesaw" effect, with the ten-year government bond yield rising to 1.8552% as of October 21, 2023, up nearly 20 basis points since June 30 [7] - Institutions like招商基金 believe that the bond market will not enter a sustained "bear" phase, but caution that credit bonds may lack independent trends due to market fluctuations [7][8]
公募把脉四季度:A股具备长期投资价值 投资主线聚焦AI、创新药等
Bei Jing Shang Bao·2025-10-22 00:44